^
Association details:
| Biomarker: | AR positive |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | FT-6876 (CBP inhibitor, EP300 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Abstract 3079: FT-6876, a potent and selective inhibitor of CBP/p300 with antitumor activity in AR-positive breast cancer
Published date:
05/15/2020
Excerpt:
FT-6876 is a promising new CBP/p300 bromodomain inhibitor demonstrating efficacy in preclinical models of AR+ breast cancer.
DOI:
10.1158/1538-7445.AM2020-3079
